Literature DB >> 2931096

Ex vivo effects of nifedipine, nisoldipine and nitrendipine on filterability of red blood cells from healthy volunteers.

S O Sowemimo-Coker, N M Debbas, I B Kovacs, P Turner.   

Abstract

In a balanced, randomised and double-blind trial, the effects of single oral dose of nifedipine, nitrendipine and nisoldipine were compared with placebo in eight healthy volunteers. Red cell filterability, measured with a gravity driven filtration technique, was not significantly altered by any of the three calcium antagonists compared with placebo, when RBCs were filtered within 2 h of venepuncture. Storage of RBCs for 24 h at 25 degrees C, however, significantly reduced RBC filterability compared with 2 h (P less than 0.05), but the reduction after nifedipine and nitrendipine was significantly (P less than 0.05) less than after placebo. The above results demonstrate an effect of calcium antagonists on filterability of stored RBCs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2931096      PMCID: PMC1400681          DOI: 10.1111/j.1365-2125.1985.tb05048.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  The acute effects of nifedipine on red cell deformability in angina pectoris.

Authors:  D G Waller; H P Nicholson; S Roath
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

2.  Impaired red cell deformability in peripheral vascular disease.

Authors:  H L Reid; J A Dormandy; A J Barnes; P J Lock; T L Dormandy
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

3.  Filterability and vascular disease--II. Red cell filterability after myocardial infarction.

Authors:  J Dormandy; M Boyd; E Ernst
Journal:  Scand J Clin Lab Invest Suppl       Date:  1981

4.  Blood rheology in malignant phase hypertension.

Authors:  C Isles; G D Lowe; M M Drummond; C D Forbes; A C Kennedy; A F Lever
Journal:  Scand J Clin Lab Invest Suppl       Date:  1981

5.  An improved filtration rate for measuring red cell deformability.

Authors:  S O Sowemimo-Coker; I B Kovacs; P Turner; J D Kirby
Journal:  Biorheology Suppl       Date:  1984

6.  Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.

Authors:  G Cocco; C Strozzi; D Chu; R Amrein; E Castagnoli
Journal:  Eur J Cardiol       Date:  1979-07

7.  Metabolic dependence of red cell deformability.

Authors:  R I Weed; P L LaCelle; E W Merrill
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808

8.  Effects of verapamil on calcium-induced rigidity and on filterability of red blood cells from healthy volunteers and patients with progressive systemic sclerosis.

Authors:  S O Sowemimo-Coker; I B Kovacs; J D Kirby; P Turner
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

  8 in total
  7 in total

1.  Calcium supplementation during sepsis exacerbates organ failure and mortality via calcium/calmodulin-dependent protein kinase kinase signaling.

Authors:  Richard D Collage; Gina M Howell; Xianghong Zhang; Jennifer L Stripay; Janet S Lee; Derek C Angus; Matthew R Rosengart
Journal:  Crit Care Med       Date:  2013-11       Impact factor: 7.598

2.  Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.

Authors:  J Y Jeremy; M A Barradas; D P Mikhailidis; P Dandona
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

3.  Nisoldipine improves the impaired erythrocyte deformability correlating with elevated intracellular free calcium-ion concentration and poor glycaemic control in NIDDM.

Authors:  J Fujita; K Tsuda; T Takeda; L Yu; S Fujimoto; M Kajikawa; M Nishimura; N Mizuno; Y Hamamoto; E Mukai; T Adachi; Y Seino
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

4.  Clinical and rheological effects of nifedipine in Raynaud's phenomenon.

Authors:  D G Waller; V F Challenor; D A Francis; O S Roath
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

Review 5.  Management of Raynaud's phenomenon. Focus on newer treatments.

Authors:  S Roath
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Nisoldipine in primary Raynaud's phenomenon.

Authors:  V F Challenor; D G Waller; D A Francis; J L Francis; R Mani; S Roath
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 7.  Red blood cell rheology in sepsis.

Authors:  M Piagnerelli; K Zouaoui Boudjeltia; M Vanhaeverbeek; J-L Vincent
Journal:  Intensive Care Med       Date:  2003-06-12       Impact factor: 17.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.